<?xml version='1.0' encoding='utf-8'?>
<document id="26895981"><sentence text="Nonclinical Pharmacokinetics, Disposition, and Drug-Drug Interaction Potential of a Novel d-Amino Acid Peptide Agonist of the Calcium-Sensing Receptor AMG 416 (Etelcalcetide)."><entity charOffset="90-102" id="DDI-PubMed.26895981.s1.e0" text="d-Amino Acid" /><entity charOffset="160-173" id="DDI-PubMed.26895981.s1.e1" text="Etelcalcetide" /><pair ddi="false" e1="DDI-PubMed.26895981.s1.e0" e2="DDI-PubMed.26895981.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26895981.s1.e0" e2="DDI-PubMed.26895981.s1.e1" /></sentence><sentence text="AMG 416 (etelcalcetide) is a novel synthetic peptide agonist of the calcium-sensing receptor composed of a linear chain of seven d-amino acids (referred to as the d-amino acid backbone) with a d-cysteine linked to an l-cysteine via a disulfide bond"><entity charOffset="9-22" id="DDI-PubMed.26895981.s2.e0" text="etelcalcetide" /><entity charOffset="68-75" id="DDI-PubMed.26895981.s2.e1" text="calcium" /><entity charOffset="129-142" id="DDI-PubMed.26895981.s2.e2" text="d-amino acids" /><entity charOffset="163-175" id="DDI-PubMed.26895981.s2.e3" text="d-amino acid" /><entity charOffset="193-203" id="DDI-PubMed.26895981.s2.e4" text="d-cysteine" /><entity charOffset="217-227" id="DDI-PubMed.26895981.s2.e5" text="l-cysteine" /><entity charOffset="234-243" id="DDI-PubMed.26895981.s2.e6" text="disulfide" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e0" e2="DDI-PubMed.26895981.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e0" e2="DDI-PubMed.26895981.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e0" e2="DDI-PubMed.26895981.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e0" e2="DDI-PubMed.26895981.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e0" e2="DDI-PubMed.26895981.s2.e4" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e0" e2="DDI-PubMed.26895981.s2.e5" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e0" e2="DDI-PubMed.26895981.s2.e6" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e1" e2="DDI-PubMed.26895981.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e1" e2="DDI-PubMed.26895981.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e1" e2="DDI-PubMed.26895981.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e1" e2="DDI-PubMed.26895981.s2.e4" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e1" e2="DDI-PubMed.26895981.s2.e5" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e1" e2="DDI-PubMed.26895981.s2.e6" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e2" e2="DDI-PubMed.26895981.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e2" e2="DDI-PubMed.26895981.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e2" e2="DDI-PubMed.26895981.s2.e4" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e2" e2="DDI-PubMed.26895981.s2.e5" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e2" e2="DDI-PubMed.26895981.s2.e6" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e3" e2="DDI-PubMed.26895981.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e3" e2="DDI-PubMed.26895981.s2.e4" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e3" e2="DDI-PubMed.26895981.s2.e5" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e3" e2="DDI-PubMed.26895981.s2.e6" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e4" e2="DDI-PubMed.26895981.s2.e4" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e4" e2="DDI-PubMed.26895981.s2.e5" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e4" e2="DDI-PubMed.26895981.s2.e6" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e5" e2="DDI-PubMed.26895981.s2.e5" /><pair ddi="false" e1="DDI-PubMed.26895981.s2.e5" e2="DDI-PubMed.26895981.s2.e6" /></sentence><sentence text=" AMG 416 contains four basic d-arginine residues and is a +4 charged peptide at physiologic pH with a mol"><entity charOffset="29-39" id="DDI-PubMed.26895981.s3.e0" text="d-arginine" /></sentence><sentence text=" wt" /><sentence text=" of 1048" /><sentence text="3 Da" /><sentence text=" The pharmacokinetics (PK), disposition, and potential of AMG 416 to cause drug-drug interaction were investigated in nonclinical studies with two single (14)C-labels placed either at a potentially metabolically labile acetyl position or on the d-alanine next to d-cysteine in the interior of the d-amino acid backbone"><entity charOffset="219-225" id="DDI-PubMed.26895981.s7.e0" text="acetyl" /><entity charOffset="245-254" id="DDI-PubMed.26895981.s7.e1" text="d-alanine" /><entity charOffset="263-273" id="DDI-PubMed.26895981.s7.e2" text="d-cysteine" /><entity charOffset="297-309" id="DDI-PubMed.26895981.s7.e3" text="d-amino acid" /><pair ddi="false" e1="DDI-PubMed.26895981.s7.e0" e2="DDI-PubMed.26895981.s7.e0" /><pair ddi="false" e1="DDI-PubMed.26895981.s7.e0" e2="DDI-PubMed.26895981.s7.e1" /><pair ddi="false" e1="DDI-PubMed.26895981.s7.e0" e2="DDI-PubMed.26895981.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26895981.s7.e0" e2="DDI-PubMed.26895981.s7.e3" /><pair ddi="false" e1="DDI-PubMed.26895981.s7.e1" e2="DDI-PubMed.26895981.s7.e1" /><pair ddi="false" e1="DDI-PubMed.26895981.s7.e1" e2="DDI-PubMed.26895981.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26895981.s7.e1" e2="DDI-PubMed.26895981.s7.e3" /><pair ddi="false" e1="DDI-PubMed.26895981.s7.e2" e2="DDI-PubMed.26895981.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26895981.s7.e2" e2="DDI-PubMed.26895981.s7.e3" /></sentence><sentence text=" After i" /><sentence text="v" /><sentence text=" dosing, the PK and disposition of AMG 416 were similar in male and female rats" /><sentence text=" Radioactivity rapidly distributed to most tissues in rats with intact kidneys, and renal elimination was the predominant clearance pathway" /><sentence text=" No strain-dependent differences were observed" /><sentence text=" In bilaterally nephrectomized rats, minimal radioactivity (1" /><sentence text="2%) was excreted via nonrenal pathways" /><sentence text=" Biotransformation occurred primarily via disulfide exchange with endogenous thiol-containing molecules in whole blood rather than metabolism by enzymes, such as proteases or cytochrome P450s; the d-amino acid backbone remained unaltered"><entity charOffset="42-51" id="DDI-PubMed.26895981.s15.e0" text="disulfide" /><entity charOffset="77-82" id="DDI-PubMed.26895981.s15.e1" text="thiol" /><entity charOffset="197-209" id="DDI-PubMed.26895981.s15.e2" text="d-amino acid" /><pair ddi="false" e1="DDI-PubMed.26895981.s15.e0" e2="DDI-PubMed.26895981.s15.e0" /><pair ddi="false" e1="DDI-PubMed.26895981.s15.e0" e2="DDI-PubMed.26895981.s15.e1" /><pair ddi="false" e1="DDI-PubMed.26895981.s15.e0" e2="DDI-PubMed.26895981.s15.e2" /><pair ddi="false" e1="DDI-PubMed.26895981.s15.e1" e2="DDI-PubMed.26895981.s15.e1" /><pair ddi="false" e1="DDI-PubMed.26895981.s15.e1" e2="DDI-PubMed.26895981.s15.e2" /></sentence><sentence text=" A substantial proportion of the plasma radioactivity was covalently conjugated to albumin" /><sentence text=" AMG 416 presents a low risk for P450 or transporter-mediated drug-drug interactions because it showed no interactions in vitro" /><sentence text=" These studies demonstrated a (14)C label on either the acetyl or the d-alanine in the d-amino acid backbone would be appropriate for clinical studies"><entity charOffset="56-62" id="DDI-PubMed.26895981.s18.e0" text="acetyl" /><entity charOffset="70-79" id="DDI-PubMed.26895981.s18.e1" text="d-alanine" /><entity charOffset="87-99" id="DDI-PubMed.26895981.s18.e2" text="d-amino acid" /><pair ddi="false" e1="DDI-PubMed.26895981.s18.e0" e2="DDI-PubMed.26895981.s18.e0" /><pair ddi="false" e1="DDI-PubMed.26895981.s18.e0" e2="DDI-PubMed.26895981.s18.e1" /><pair ddi="false" e1="DDI-PubMed.26895981.s18.e0" e2="DDI-PubMed.26895981.s18.e2" /><pair ddi="false" e1="DDI-PubMed.26895981.s18.e1" e2="DDI-PubMed.26895981.s18.e1" /><pair ddi="false" e1="DDI-PubMed.26895981.s18.e1" e2="DDI-PubMed.26895981.s18.e2" /></sentence><sentence text="" /></document>